PMS12 COST-EFFECTIVENESS ANALYSIS OF ZOLEDRONIC ACID VERSUS RISEDRONATE FOR THE PREVENTION OF OSTEOPOROTIC HIP FRACTURE IN THE PRIVATE HEALTH CARE SYSTEM IN BRAZIL
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70814-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)70814-7/fulltext
Section Title :
Section Order :
564
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70814-7&doi=10.1016/S1098-3015(10)70814-7